The PDGF-C regulatory region SNP rs28999109 decreases promoter transcriptional activity and is associated with CL/P
Tóm tắt
Từ khóa
Tài liệu tham khảo
Jugessur A, Murray JC : Orofacial clefting: recent insights into a complex trait. Curr Opin Genet Dev 2005; 15: 270–278.
Mossey P : Epidemiology underpinning research in the aetiology of orofacial clefts. Orthod Craniofac Res 2007; 10: 114–120.
Juriloff DM, Harris MJ, Brown CJ : Unraveling the complex genetics of cleft lip in the mouse model. Mamm Genome 2001; 12: 426–435.
Murray JC, Schutte BC : Cleft palate: players, pathways, and pursuits. J Clin Invest 2004; 113: 1676–1678.
Vieira AR, Avila JR, Daack-Hirsch S et al: Medical sequencing of candidate genes for nonsyndromic cleft lip and palate. PLoS Genet 2005; 1: 651–659.
Rahimov F, Marazita ML, Visel A et al: Disruption of an AP-2alpha binding site in an IRF6 enhancer is associated with cleft lip. Nat Genet 2008; 40: 1341–1347.
Brewer C, Holloway S, Zawalnyski P, Schinzel A, FitzPatrick DA : Chromosomal deletion map of human malformations. Am J Hum Genet 1998; 63: 1153–1159.
Lin AE, Garver KL, Diggans G et al: Interstitial and terminal deletions of the long arm of chromosome 4: further delineation of phenotypes. Am J Med Genet 1988; 31: 533–548.
Beiraghi S, Foroud T, Diouhy S et al: Possible localization of a major gene for cleft lip and palate to 4q. Clin Genet 1994; 46: 255–256.
Mitchell LE, Healey SC, Chenevix-Trench G : Evidence for an association between nonsyndromic cleft lip with or without cleft palate and a gene located on the long arm of chromosome 4. Am J Hum Genet 1995; 57: 1130–1136.
Paredes M, Carreno H, Sola JA, Segu J, Palomino H, Blanco R : Association between nonsyndromic cleft lip/palate with microsatellite markers located in 4q. Rev Med Chil 1999; 127: 1431–1438.
Marazita ML, Field LL, Cooper ME et al: Genome-scan for loci involved in cleft lip with or without cleft palate in Chinese multiplex families. Am J Hum Genet 2002; 71: 349–364.
Ding H, Wu X, Bostrom H et al: A specific requirement for PDGF-C in palate formation and PDGFR-alpha signaling. Nat Genet 2004; 36: 1111–1116.
Avila JR, Jezewski PA, Vieira AR et al: PVRL1 variants contribute to non-syndromic cleft lip and palate in multiple populations. Am J Med Genet 2006; 140: 2562–2570.
Zucchero TM, Cooper ME, Maher BS et al: Interferon regulatory factor 6 (IRF6) gene variants confer risk for isolated cleft lip and palate. New Engl J Med 2004; 351: 769–780.
Jezewski PA, Vieira AR, Nishimura C et al: Complete sequencing shows a role for MSX1 in non-syndromic cleft lip and palate. J Med Genet 2003; 40: 399–407.
Marazita ML, Murray JC, Lidral AC et al: Meta-analysis of 13 genome scans reveals multiple cleft lip/palate genes with novel loci on 9q21 and 2q32–35. Am J Hum Genet 2004; 75: 161–173.
Neiswanger K, Deleyiannis FW, Avila JR et al: Candidate genes for oral-facial clefts in Guatemalan families. Ann Plast Surg 2006; 56: 518–521.
Letra A, Menezes R, Granjeiro JM et al: Defining subphenotypes for oral clefts based on dental development. J Dent Res 2007; 86: 986–991.
Grabe N : AliBaba2: context specific identification of transcription factor binding sites. In Silico Biol 2002; 2: S1–S15.
Choi SJ, Oba T, Callander NS, Jelinek DF, Roodman GD : AML-1A and AML-1B regulation of MIP-1alpha expression in multiple myeloma. Blood 2003; 101: 3778–3783.
Choi SJ, Song IS, Ryu OH et al: A 4 bp deletion mutation in DLX3 enhances osteoblastic differentiation and bone formation in vitro. Bone 2008; 42: 162–171.
O'Connell JR, Weeks DE : PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63: 259–266.
Horvath S, Xu X, Laird NM : The family based association test method: strategies for studying general genotype – phenotype associations. Eur J Hum Genet 2001; 9: 301–306.
Betsholtz C, Karlsson L, Lindahl P : Developmental roles of platelet-derived growth factors. Bioessays 2001; 23: 494–507.
Khachigian LM, Williams AJ, Collins T : Interplay of Sp1 and Egr-1 in the proximal platelet-derived growth factor A-chain promoter in cultured vascular endothelial cells. J Biol Chem 1995; 270: 27679–27686.
Midgley VC, Khachigian LM : Fibroblast growth factor-2 induction of platelet-derived growth factor-C chain transcription in vascular smooth muscle cells is ERK-dependent but not JNK-dependent and mediated by Egr-1. Biol Chem 2004; 279: 40289–40295.
Han J, Xiao Y, Lin J, Li Y : PDGF-C controls proliferation and is down-regulated by retinoic acid in mouse embryonic palatal mesenchymal cells. Birth Defects Res 2006; 77: 438–444.
Han J, Li L, Zhang Z et al: Platelet-derived growth factor C plays a role in the branchial arch malformations induced by retinoic acid. Birth Defects Res A Clin Mol Teratol 2007; 79: 221–230.
Reigstad LJ, Varhaug JE, Lillehaug JR : Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family. FEBS J 2005; 272: 5723–5741.
Schmahl J, Raymond CS, Soriano P : PDGF signaling specificity is mediated through multiple immediate early genes. Nat Genet 2007; 39: 52–60.
Chen WV, Delrow J, Corrin PD, Frazier JP, Soriano P : Identification and validation of PDGF transcriptional targets by microarray-coupled gene-trap mutagenesis. Nat Genet 2004; 36: 304–312.
Soriano P : The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. Development 1997; 124: 2691–2700.
Li X, Pontén A, Aase K et al: PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol 2000; 2: 302–309.
Liu L, Korzh V, Balasubramaniyan NV, Ekker M, Ge R : Platelet-derived growth factor A (pdgf-a) expression during zebrafish embryonic development. Dev Genes Evol 2002; 212: 298–301.
Eberhart JK, He X, Swartz ME et al: MicroRNA Mirn140 modulates Pdgf signaling during palatogenesis. Nat Genet 2008; 40: 290–298.
Maul RS, Zhang H, Reid IV JD, Pedigo NG, Kaetzel DM : Identification of a cell type-specific enhancer in the distal 5′-region of the platelet-derived growth factor A-chain gene. J Biol Chem 1998; 273: 33239–33246.
Sanchez-Guerrero E, Midgley VC, Khachigian LM : Angiotensin II induction of PDGF-C expression is mediated by AT1 receptor-dependent Egr-1 transactivation. Nucleic Acids Res 2008; 36: 1941–1951.
Scharnhorst V, Menke AL, Attema J et al: EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity. Oncogene 2000; 19: 791–800.
Han J, Li L, Zhang Z, Xiao Y, Lin J, Li Y : PDGF-C participates in branchial arch morphogenesis and is down-regulated by retinoic acid. Toxicol Lett 2006; 166: 248–254.
Jinnin M, Ihn H, Mimura Y, Asano Y, Yamane K, Tamaki K : Regulation of fibrogenic/fibrolytic genes by platelet-derived growth factor C, a novel growth factor, in human dermal fibroblasts. J Cell Physiol 2005; 202: 510–517.
Reigstad LJ, Martinez A, Varhaug JE, Lillehaug JR : Nuclear localisation of endogenous SUMO-1-modified PDGF-C in human thyroid tissue and cell lines. Exp Cell Rse 2006; 312: 782–795.
Alkuraya FS, Saadi I, Lund JJ, Turbe-Doan A, Morton CC, Maas RL : SUMO1 haploinsufficiency leads to cleft lip and palate. Science 2006; 313: 1751.
Pauws E, Stanier P : FGF signaling and SUMO modification: new players in the aetiology of cleft lip and/or palate. Trends Genet 2007; 23: 631–640.